TREATMENT OF BRANCH RETINAL ARTERIAL-OCCLUSION WITH SODIUM OZAGREL, ATHROMBOXANE A(2) SYNTHETASE INHIBITOR

Authors
KATO H EMURA S TAKEUCHI N ENOKI M OOGUSHI K TAKASHIMA T OHMORI K SAITO I
Citation
H. Kato et al., TREATMENT OF BRANCH RETINAL ARTERIAL-OCCLUSION WITH SODIUM OZAGREL, ATHROMBOXANE A(2) SYNTHETASE INHIBITOR, Journal of international medical research, 25(2), 1997, pp. 108-111
Citations number
10
Categorie Soggetti
Pharmacology & Pharmacy","Medicine, Research & Experimental
Journal title
Journal of international medical research → ACNP
ISSN journal
03000605
Volume
25
Issue
2
Year of publication
1997
Pages
108 - 111
Database
ISI
SICI code
0300-0605(1997)25:2<108:TOBRAW>2.0.ZU;2-#
Abstract
A 47-year-old woman with branch retinal arterial occlusion treated wit h sodium ozagrel is described, The patient presented with acute visual field loss in her right eye, Blood tests demonstrated the elevation o f beta-thromboglobulin and platelet factor 4. Sodium ozagrel, a thromb oxane A(2) synthetase inhibitor, 160 mg daily was administered for 14 days. This treatment prevented exacerbation of retinal arterial thromb osis and produced a marked improvement in the visual field loss. Sodiu m ozagrel may be a useful drug in the treatment of acute retinal arter ial occlusion thought to be caused by thrombosis.